ICAM1 and neoplasm: Such improved tumor penetration ability of ICAM1‐ADC induced by DAC may yield greater efficacy and improve clinical success rates for ADCs, since solid tumor tissue penetration holds the key for their clinical efficacy.[38] Our findings provide in vivo evidence that DAC pretreatment improves tumor penetration of ADCs.